46 results about "Melatonin secretion" patented technology

An optical filter and a lighting device using the same wherein the suppression of the melatonin secretion by the reception of light in the nighttime is prevented and the color of light is maintained. The optical filter has a mean transmissivity of a light beam in a wavelength range of about 480˜550 nm is about 30% or less. The optical filter is formed by at least molding a transparent resin and a resin composition material containing an orange color series florescent dye material, and, for 100 weight part of the transparent resin, the resin composition material containing about 0.005˜0.2 weight part of the orange color series florescent dye material is molded. This can prevent the suppression of the melatonin secretion in the nighttime. The color of light is maintained desirable. The optical filter may be applied to a lighting apparatus.

A light emitting device to awaken an animal and stimulate the Suprachiasmatic Nucleus in the brain to suppress melatonin secretion. The device can be programmed for an initiation time, color of light, brightness, frequency of pulsating light, and level of gradual intensity. It has the advantage of being silent and does not to disturb other people sleeping in the same room.

A lighting apparatus enabling lighting adequate for time or the lifestyle of the user by regulating the intensity of light in the wavelength region leading to reduction of melatonin secretion and emitted from a luminous portion of the lighting apparatus toward the eyes of the user and thereby varying the influence of the light on melatonin secretion reduction. First and second luminous portions (3, 3, ..., 4, 4, ...) having different luminous intensity distribution characteristics are used in the lighting apparatus. A control section of the lighting apparatus controls the luminous intensitiesof the first and second luminous portions (3, 3, ..., 4, 4, ...) so as to vary the intensity of light in the wavelength region reducing the melatonin secretion and emitted in a predetermined direction. Consequently, the intensity of light emitted toward the eyes of the human (in the predetermined direction) in a normal usage mode is varied, and thus the intensity of light in the wavelength regionentering the eyes of the human and reducing the melatonin secretion is regulated. With this, the influence on the melatonin secretion reduction can be varied, and lighting adequate for time or the lifestyle of the user is achieved.

Fluorescent lamp 100 has a light color with a correlated color temperature higher than 10000 [K] and lower than 17000 [K] and Duv in a range of −2.5 to 5, comprising arc tube 10 and phosphor layer 20 which includes at least: a red emitting rare-earth phosphor with a main emission peak (11) in 605-625 [nm]; a green emitting rare-earth phosphor with a main emission peak (12) in 540-550 [nm]; and a blue emitting rare-earth phosphor with a main emission peak (13) in 440-460 [nm], an action function efficiency of melatonin suppression for per unit luminous flux is higher than 1.0, and a general color rendering index Ra is 80 or higher. With the stated structure, the fluorescent lamp 100 suppresses melatonin secretion thereby achieving effects of adjusting biological rhythms and promoting wakefulness of living bodies, and also remedies the shortcomings in color rendering characteristics of the light source.

A light emitting device to awaken an animal and stimulate the Suprachiasmatic Nucleus in the brain to suppress melatonin secretion. The device can be programmed for an initiation time, color of light, brightness, frequency of pulsating light, and level of gradual intensity. It has the advantage of being silent and does not to disturb other people sleeping in the same room.

The invention relates to a low-pressure gas-discharge lamp which, with its light in the red spectral region, influences the biological circadian rhythm by controlling melatonin secretion. The tubular glass discharge vessel, which can also be in the shape of a double helix, is filled with a noble gas or noble-gas mixture and mercury. Electrodes for the supply of energy are arranged at both ends of the discharge vessel. The discharge vessel is multicoated on the inside by phosphor layers applied one after the other. The first phosphor layer located on the glass surface consists of phosphor which is excited both by ultraviolet mercury radiation between 180 nm and 400 nm and also by the blue radiation between 400 nm and 490 nm emitted by the mercury discharge, and by the visible radiation emitted by the second or further phosphor layers between 400 nm and 550 nm, where visible light having emission maxima in the region between 500 nm and 650 nm is generated. In combination with light sources for melatonin suppression, the low-pressure gas-discharge lamp is, with its warm light, particularly suitable for stimulation of the quasi-circadian rhythm in an individual in the absence of external conditions, such as sunlight. Owing to its good colour reproduction and high energy efficiency, it meets all necessary requirements of a light source for illumination tasks and is thus also suitable for general lighting.

A light emitting device to awaken or alert an animal by stimulating the Suprachiasmatic Nucleus in the brain to suppress melatonin secretion and change gene expression in the brain. The device can be programmed for an initiation time, color of light, brightness, frequency of pulsating light, and level of gradual intensity. It has the advantage of being silent, does not to disturb other people sleeping in the same room and user is more cognitively alert.

The invention relates to eye-protecting and sleep-facilitating healthy glasses. The glasses are characterized in that according to the light transmittance of lenses, the transmittance of a 400-520 nm spectral interval is 10-35%, the transmittance of a 540-569 nm spectral interval is 35-96%, the transmittance of a 570-600 nm spectral interval is 92-97%, and the transmittance of a 600-700 nm spectral interval is 88-93%. The eye-protecting and sleep-facilitating healthy glasses can stop and optimize a spectrum waveband which is sensed by SCN ganglion cells and can stop melatonin secretion or reduce the secretion amount and will not affect normal work and life of people after being worn, wherein the work and life do not contain work and life needing accurate colors; the glasses serve as a means for improving sleep quality of modern human beings and treating or assisting in treating insomnia of patients with sleep disorder and other symptoms.

Disclosures of the present invention describe a method for inhibiting melatonin secretion. In the present invention, an illumination device is particularly configured for emitting an illumination light with a specific wavelength that is in a range between 581 nm and 590 nm, and a variety of experimental data have proved that the illumination light functions as a melatonin secretion inhibitor. Therefore, the illumination device of the present invention is evidenced to be suitable for use in light therapy, so as to treat seasonal affective disorder (SAD) by way of inhibiting melatonin secretion. Briefly speaking, after a SAD patient receives the irradiation of the illumination light having wavelength ranged in 581-590 nm for a treatment course, the SAD patient is eventually leaded to stay in good spirits and a stable condition of emotion, thereby curing the abnormal symptoms of sleepiness and emotional disorder.

Disclosed in the invention is an intelligent sleeping device. The device is characterized in that more than one light emitting module group is arranged on a main body; and when in use, the light emitting module group faces eyes of the user. According to the invention, the light emitted by the light emitting module group radiates the eyes to simulate the sunlight radiation and thus nnormalization of melatonin secretion of the human body can be promoted, thereby effectively improving sleeping of the user. Therefore, the device can be used for adjusting the normal sleeping of people and improving the sleeping quality of the insomniac; and certain help can be provided for people travelling frequently at long distance to carry out jet lag operation.

The present invention discloses a sleep improving soybean oligopeptide health-care food which is characterized by comprising the following raw materials in mass percentage: 60-70% of soybean oligopeptides, 20-30% of compound sweeteners and 6-12% of honey powder. The provided health-care food has a synergistic use of the advantages of the soybean oligopeptides and honey powder. After the raw materials are blended, the consumption of the health-care food has functions of improving the cerebral blood supply, improving the regulatory function of the cerebral cortex, and thus achieves the roles of calming mind and promoting hypnosis, and calming heart and smoothing nerves, and has a relative good function in improving sleep. Especially the health-care food can enable the nutrients in brain to be balancedly absorbed and promote melatonin secretion, and effectively regulate the human body natural sleep, overcome sleep disorders, improve sleep quality, prevent oxidation, tonify brain cells, and treat intractable insomnia, and is free of reliance with no rebound, and has no side effects on the human body.

The invention discloses a liquid crystal display panel, a liquid crystal display device and a manufacturing method for the liquid crystal display panel. The liquid crystal display panel comprises a first substrate, a second substrate and a liquid crystal layer arranged between the first substrate and the second substrate, the first substrate comprises a substratum and a thin film transistor arranged on the substratum, a color resistance layer is further arranged on the first substrate, the color resistance layer comprises a blue color resistor, a red resistor and a green color resistor, and quantum dot layers are stacked at one side, away from the substratum, of the blue resistor. According to the liquid crystal display panel, the liquid crystal display device and the manufacturing methodfor the liquid crystal display panel, it is due to the fact that the quantum dot layers are arranged on the corresponding position of the blue resistor, quantum dots on the quantum dot layer are motivated by a backlight module, high-energy blue light can be eliminated, the effect of protecting eyesight is achieved, and melatonin secretion cannot be affected; in addition, it is only required that the quantum dot layers are additionally arranged on the original multicolor resistance layer, the multicolor resistance layer does not need to be changed excessively, and increasing extra expenses is not needed.

The invention discloses a preparation method for an OLED insect-repelling lamp. According to the method, with an OLED, a light-emitting spectrum is controlled based on regulation of a blue-light emitting material, a green-light emitting material, a yellow-light emitting material and a red-light emitting material, so that the light-emitting wavebands are centralized to be at 530nm to 590nm and are at a red-light waveband. And the color rendering index of the OLED is larger than or equal to 65. The preparation method has the following advantages: firstly, the method is simple; with the OLED, the light-emitting spectrum can be controlled based on material regulation and the insect-repelling wavebands from 530nm to 590nm are highlighted in the spectrum, so that the insect-repelling effect is realized; secondly, illumination can be realized well; to be specific, because the light-emitting waveband includes a very few blue-light wavebands of 500nm below and also includes an appropriate number of red-light wavebands, so that the illumination effect is realized; and thirdly, the practicability of the method is high and the color temperature is low; and when the method is applied at night, the injury of the human eyes due to the blue light can be reduced and the suppression on melatonin secretion by the high-color-temperature illumination can be avoided.

The invention discloses an office lighting adjustment method and system. The method comprises the steps of acquiring a preset detection time frame; acquiring whether an office worker is at each office desk or not in real within the detection time frame; turning on an individual light source corresponding to the office desk at which the office worker is when the office worker is at the office desk; adjusting a mode of the individual light source to a highlight state; adjusting a lighting state of the individual light source according to the highlight state; maintaining the lighting state for 30 minutes; and finishing detection and turning off the individual light source. According to the method and the system, disclosed by the invention, the office worker is enabled to receive enough lighting stimulation within an appropriate time frame by adjusting lighting in an office, the influence on melatonin secretion is further generated, so that the working efficiency of the office worker is obviously improved, and the sleep quality of the office worker is adjusted to a certain extent.

Disclosed is a fluorescent lamp (100) having a light color with a correlated color temperature of more than 10,000 [K] and less than 17,000 [K] and DUV in the range of -2.5 to 5. The fluorescent lamp (100) comprises a lamp arc tube (10) and a phosphor layer (20). The phosphor layer (20) comprises at least a red light emitting rare earth phosphor, which serves as a luminescent center having a main emission peak (11) within 605 to 625 [nm], a green light emitting rare earth phosphor, which serves as a luminescent center having a main emission peak (12) within 540 to 550 [nm], and a blue light emitting rare earth phosphor, which serves as a luminescent center having a main emission peak (13) within 440 to 460 [nm]. The fluorescent lamp has an action function efficiency for melatonin suppression per unit light flux of more than 1.0 and an average color rendering index Ra of not less than 80. According to the above constitution, the fluorescent lamp allows to attain the function and effect of regulating the biological rhythm and promoting wakefulness of a living body while suppressing melatonin secretion and besides improves the drawbacks in color rendering characteristic of the light source.

The invention provides agents for phase-adjusting or enhancing the amplitude of an endogenous melatonin secretion rhythm and for improving a circadian rhythm, which may be taken daily and continuously, have excellent safety, and may effectively prevent or ameliorate disorders of an endogenous melatonin secretion rhythm or of a circadian rhythm without administration of exogenous melatonin, as well as functional food containing such an agent, which may prevent or ameliorate various symptoms, such as sleep disorder or prolonged sleep latency. The agent for phase-adjusting or enhancing the amplitude of an endogenous melatonin secretion rhythm according to the invention contains whey as the active component. The functional food for improving an endogenous melatonin secretion rhythm according to the invention contains the agent for phase-adjusting or enhancing the amplitude of an endogenous melatonin secretion rhythm. The functional food for improving a circadian rhythm contains the agent for improving a circadian rhythm.

The invention relates to a low-pressure gas discharge lamp influencing the biological circadian rhythm by controlling melatonin secretion by means of the light thereof in the red spectral range. The tube-shaped glass discharge vessel, which can also be formed as a double helix, is filled with a noble gas or noble gas mixture and mercury. Electrodes for infeeding energy are disposed at both ends of the discharge vessel. The discharge vessel is coated on the inside in multiple layers by successively applied fluorescent layers. The first fluorescent layer is made of an illuminant excited by the ultraviolet mercury radiation between 180 nm and 400 nm, and by the blue radiation between 400 nm and 490 nm emitted by the mercury discharge, and by the emitted visible radiation of the second or further fluorescent layer between 400 and 550 nm, wherein visible light having emissions maxima in the range from 500 nm to 650 nm is generated. Together with light sources for melatonin suppression, the low-pressure gas discharge lamp, having warm light thereof, is particularly suitable for simulating the quasi-circadian rhythm of an individual when external conditions, such as sunlight, are missing. Due to the good color reproduction and high energy efficiency thereof, it meets all necessary requirements of a light source for illumination tasks, and is therefore also suitable for general lighting.

The invention discloses a functional streptokinase product improving sleep. The functional streptokinase product improving sleep is prepared from the following components in parts by weight: 1-15 parts of streptokinase powder, 5-10 parts of bacillus subtilis powder, 20-35 parts of wild jujube powder, 15-20 parts of semen cassiae powder, 15-25 parts of rhizoma gastrodiae powder, 15-25 parts of radix polygoni multiflori, 15-25 parts of flos chrysanthemi powder and 3-5 parts of radix glycyrrhizae powder. Wild jujube, semen cassiae, rhizoma gastrodiae, radix polygoni multiflori, flos chrysanthemiand radix glycyrrhizae have a certain action of promotion of melatonin secretion, and thus the sleep quality of a human body is improved. The invention further discloses a preparation method of the functional streptokinase product improving sleep.

The invention provides a method for inhibiting melatonin secretion by using a light source. According to the method, a lighting device is specially designed to emit lighting light having a specific wavelength within the wavelength range of 581nm and 590nm, and various experimental data have proved that the lighting light can be used to serve as a melatonin secretion inhibitor. Therefore, the experimental data have proved that the lighting device of the invention is suitable for being used for light therapy for winter depression, thereby treating the seasonal affective disorder (namely the winter depression) by inhibiting the melatonin secretion. Briefly speaking, after a patient suffering from the winter depression receives a treatment course of the light therapy with the lighting light with the wavelength range of 581-590nm, the symptoms of the winter depression, including somnolence, emotional disorder and the like, of the patient suffering from the winter depression can be cured finally due to the fact that the patient has a good mental state and a stable emotional state.

The invention provides an application of albiflorin or pharmaceutically acceptable salts of albiflorin to preparation of human melatonin system function improving products. Albiflorin or the pharmaceutically acceptable salts of albiflorin serving as an endogenous melatonin secretion accelerant and a melatonin receptor stimulant can be used for preparing drugs, food, health care products, food additives or nutritional supplements for improving and treating sub-health statuses and / or diseases caused by melatonin system dysfunction, wherein the sub-health statuses are selected from one or more of biological rhythm disorder type sleep disorder, senile sleep disorder, affective disorder, cognitive disorder and immune system dysfunction; the diseases are selected from one or more of depression, anxiety disorder, Alzheimer's disease and Parkinson's disease.

The invention provides agents for phase-adjusting or enhancing the amplitude of an endogenous melatonin secretion rhythm and for improving a circadian rhythm, which may be taken daily and continuously, have excellent safety, and may effectively prevent or ameliorate disorders of an endogenous melatonin secretion rhythm or of a circadian rhythm without administration of exogenous melatonin, as well as functional food containing such an agent, which may prevent or ameliorate various symptoms, such as sleep disorder or prolonged sleep latency. The agent for phase-adjusting or enhancing the amplitude of an endogenous melatonin secretion rhythm according to the invention contains whey as the active component. The functional food for improving an endogenous melatonin secretion rhythm according to the invention contains the agent for phase-adjusting or enhancing the amplitude of an endogenous melatonin secretion rhythm. The functional food for improving a circadian rhythm contains the agent for improving a circadian rhythm.

The invention provides a light environment adjusting system and adjusting method suitable for public health safety; the system comprises a lamp with adjustable illumination parameters, a server and asensor; the server is respectively connected with the lamp with adjustable illumination parameters and the sensor, and the system also comprises a terminal device and a physical switch, and the terminal equipment and the physical switch are connected with the server. According to the light environment adjusting system and method suitable for public health safety, the relation between the illumination parameters and melatonin secretion and physiological indexes related to new coronal pneumonia is comprehensively considered, a relation model M1 and a relation model M2 are established, the current scene can be automatically judged, and different illumination environments are provided for different scenes; the lighting requirements in different scenes are met; by providing different illuminations, the patient can maintain biological rhythms and physiological parameters as normal as possible, and recovery of the patient is promoted.

The invention relates to the technical field of LED lighting, and provides an LED light source which comprises a chip; and a fluorescent layer coated at the light emitting side of the chip. In the light rays generated by the LED light source, the relative spectral power of the wave band of 450nm and 500nm is less than 1 percent. The LED light source disclosed by the invention can meet the home lighting requirements, especially the lighting requirements of the bedrooms and living rooms, and reduce the influence of the light source on melatonin secretion inhibition at night, so that people havea good pre-sleep light source environment.

The invention relates to the technical field of LED lighting, and provides an LED light source which comprises a chip, wherein the peak wavelength of chip is 400 nm and 425 nm; and a fluorescent layerwhich is coated at the light emitting side of the chip. In the light rays generated by the LED light source, the relative spectral power of the wave band of 450nm and 500nm is less than 3 percent. The LED light source disclosed by the invention can meet the home lighting requirements, especially the lighting requirement of the bedrooms and living rooms, and reduce the influence of the light source on melatonin secretion inhibition at night, so that people have a good pre-sleep light source environment.

Disclosures of the present invention describe a method for inhibiting melatonin secretion. In the present invention, an illumination device is particularly configured for emitting an illumination light with a specific wavelength that is in a range between 581 nm and 590 nm, and a variety of experimental data have proved that the illumination light functions as a melatonin secretion inhibitor. Therefore, the illumination device of the present invention is evidenced to be suitable for use in light therapy, so as to treat seasonal affective disorder (SAD) by way of inhibiting melatonin secretion. Briefly speaking, after a SAD patient receives the irradiation of the illumination light having wavelength ranged in 581-590 nm for a treatment course, the SAD patient is eventually leaded to stay in good spirits and a stable condition of emotion, thereby curing the abnormal symptoms of sleepiness and emotional disorder.

The invention belongs to the technical field of moon cake production and particularly relates to a production method of a lemon cake type moon cake. The production method specially comprises the stepsas follows: (1) production of a moon cake wrapper; (2) production of moon cake filling; and (3) production of the lemon cake type moon cake: the moon cake wrapper is filled with the moon cake filling, the moon cake is placed in a mold, the mold is placed in a baking oven for baking and then taken out, demolding is conducted, and the lemon cake type moon cake is obtained. The obtained moon cake tastes fragrant, soft, unique and sweet and sour palatably and can promote balanced absorption of nutritional ingredients by the brain of an eater, promote melatonin secretion, effectively regulate natural sleep of the human body, overcome sleep disorders, improve sleep quality, resist oxidation, nourish brain cells, effectively help digestion, remove swelling, eliminate dampness, promote circulation of qi, warm stomach, promote gastric secretion, enhance metabolism capacity, effectively prevent and relieve constipation, clear heat, reduce internal heat, remove toxins and eliminate bad breath, the expiration date of the moon cake can be effectively prolonged, and the eating rate and the eating nutrition and healthcare effects can be improved.

The problem of the present invention is to provide a melatonin secretion regulator capable of regulating melatonin secretion in vivo; this problem is solved by providing a melatonin secretion regulator containing ornithine or a salt thereof as an active ingredient.

The invention discloses a method for determining melatonin in faeces by using high performance liquid chromatography. The method comprises the following steps: mashing and uniformly mixing to-be-determined faeces, freeze-drying the to-be-determined faeces by using a freeze dryer, leaching the to-be-determined faeces by using methanol, centrifuging, taking a supernatant, and blow-drying the supernatant by using a termovap sample concentrator; performing dissolution by using an acetonitrile n-hexane solution, centrifuging, taking a subnatant, and filtering the subnatant by using a microfiltration membrane; and performing high performance liquid chromatography detection on a machine, and quantifying the melatonin in the faeces sample by adopting an external standard method. The melatonin in the faeces is extracted and detected for the first time; the detection method is high in sensitivity, high in specificity, good in stability and accurate and reliable in result; a novel animal non-invasive melatonin detection method can be established; and the circadian rhythm of animal endogenous melatonin secretion is clarified.

The invention provides a blue-light-removing light diffusion material, photocureable coating and LED light source. The blue-light-removing light diffusion material comprises PC, an organosilicon lightdiffusion agent, a nano rare earth oxide and an antioxidant; the blue-light-removing photocureable coating is prepared from UV-cured acrylate, nano rare earth oxide, rare earth naphthenate and elargol; the blue-light-removing LED light source comprises an LED chip, a light-emitting surface of the LED chip is covered with a blue-light-removing fluorescent coating, which comprises fluorescent powder and the blue-light-removing light diffusion material and / or blue-light-removing photocureable coating. By adding rare earth elements in a proper proportion, harmful blue light is reduced, eye pathological harm and human body rhythm harm of myopia, cataract and maculopathy caused by blue light are effectively avoided, harmless blue light is added, melatonin secretion is inhibited, the effect of refreshing people is achieved, meanwhile, spectrum distribution is uniform, uniform and soft light emitting is guaranteed, glare is avoided effectively, and the light source provided by the invention is particularly suitable for replacing a fluorescent lamp in a classroom, so that the eyesight of children is protected.